Emergent BioSolutions Inc (EBS) Stock
NYQ · EBS
6.80
Fundamentals
Market cap
$348.66M
Price / Earnings ratio
-2.0x
Price / Sales ratio
0.5x
Price / Book ratio
1.1x
Return on assets
-0.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Emergent BioSolutions Inc
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees900
CEOMr. Joseph C. Papa Jr., M.B.A., R.Ph.
IPO DateNov 15, 2006
HeadquartersGaithersburg, MD
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Joseph C. Papa Jr., M.B.A., R.Ph. | CEO, President & Director | 1956 |
| Mr. Richard S. Lindahl M.B.A. | Executive VP & CFO | 1964 |
| Ms. Coleen Glessner | Executive Vice President of Quality, Ethics & Compliance | 1971 |
| Mr. Paul A. Williams | Senior Vice President of Products Business | 1967 |
| Ms. Jessica Perl | Senior VP, Corporate Secretary & General Counsel | 1981 |
| Assal Hellmer | Vice President of Communications | — |
| Ms. Michelle Pepin | Senior VP & Chief Human Resource Officer | — |
| Ms. Stephanie Duatschek | Executive VP & Chief Growth Officer | — |
| Mr. William Hartzel | Senior Vice President of Manufacturing & Bioservices | 1978 |
| Mr. Frank Vargo | VP & Treasurer |